Skip to main content
Premium Trial:

Request an Annual Quote

Microbial Boost?

Two studies plan to evaluate whether swabbing babies born via caesarian section with their mothers' microbes will boost their own microbiome and prevent disease, NPR reports.

One of the studies is taking place at the Inova hospital system and, there, researchers led by Suchitra Hourigan, a pediatric gastroenterologist, will first swab 50 babies, half with their mothers' birth canal microbiomes and half with a sterile solution, in a procedure known as vaginal seeding, NPR adds. If safe, then they plan to boost their cohort size to 800. The other study is to take place at the Icahn School of Medicine at Mount Sinai.

The thought, NPR notes, it that the procedure will lead to the microbiomes of these C-section babies to develop more like those of their vaginally delivered counterparts. And, as the number of C-section have risen around the same time as asthma, allergies, obesity, and other diseases, it may potentially cut down on disease risk as well.

"Who knows what's going to happen with the results? But if it does show something positive, I just think that would be great for kids and parents," Danielle Vukadinovich, an Inova study participant, tells NPR.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.